TP53 and neoplasm: A total of 10 years after the initial discovery of p53, Bert Vogelstein and colleagues demonstrated that p53 mutation and deletion occur at an extremely high frequency in colorectal carcinomas, providing compelling evidence that p53 functions as a tumor suppressor [3].